Trials / Recruiting
RecruitingNCT06665477
Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing
A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 162 (estimated)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane Volyme in the treatment of temple hollowing
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Volyme | Subjects in Restylane Volyme treatment group will receive treatment on Day 1 and optiponal treatment 1 month later. |
Timeline
- Start date
- 2024-11-18
- Primary completion
- 2025-12-01
- Completion
- 2026-07-01
- First posted
- 2024-10-30
- Last updated
- 2025-01-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06665477. Inclusion in this directory is not an endorsement.